|Bid||24.05 x 1200|
|Ask||68.00 x 800|
|Day's Range||58.98 - 60.42|
|52 Week Range||55.16 - 76.70|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||32.54|
|Earnings Date||Jul 26, 2022 - Aug 01, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.57|
Subscribe to Yahoo Finance Plus to view Fair Value for IART
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Hilco Redevelopment Partners (HRP) announced that Integra LifeSciences, NASDAQ: IART (https://www.integralife.com/home), a leading global medical technology company, will occupy approximately 100,000 square feet of HRP's newly redeveloped state-of-the-art life science space at 400 Wood Road in Braintree, MA. The new space will manufacture surgical reconstruction devices used in the treatment of areas such as hernia repair and breast reconstruction.
Integra's (IART) updated 2022 financial guidance calls for strong year-over-year organic growth.